The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Exhibition celebrates shared memories between Taipei, Shanghai
12/22/2024 09:04 PM - Society
Health ministry previews tighter betel nut regulations
12/22/2024 08:46 PM - Culture
Taiwan gears up for Christmas with festive events
12/22/2024 08:28 PM - Politics
Taipei 101 lights up to celebrate 90th anniversary of ROC-Guatemala ties
12/22/2024 07:51 PM - Culture
Taiwan Lantern Festival to feature baseball following historic win
12/22/2024 06:26 PM